Hepatocellular Carcinoma Cancer Immunotherapy plus Angiogenesis Inhibitors - soon the new Therapy Standard for HCC?

被引：0
|
作者：
Vetter, Christine
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：642 / 642
页数：1
相关论文
共 50 条
  • [1] IMMUNOTHERAPY OF HEPATOCELLULAR CARCINOMA (HCC)
    Shimoda, Masafumi
    Carlson, Rolf I.
    Wands, Jack R.
    [J]. HEPATOLOGY, 2010, 52 (04) : 948A - 948A
  • [2] Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy
    Fasano, Rossella
    Shadbad, Mahdi Abdoli
    Brunetti, Oronzo
    Argentiero, Antonella
    Calabrese, Angela
    Nardulli, Patrizia
    Calbi, Roberto
    Baradaran, Behzad
    Silvestris, Nicola
    [J]. LIFE-BASEL, 2021, 11 (12):
  • [3] Perspectives of immunotherapy in hepatocellular carcinoma (HCC)
    Buettner, N.
    Schmidt, N.
    Thimme, R.
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (12): : 1334 - 1342
  • [4] Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
    Bicer, Fuat
    Kure, Catrina
    Ozluk, Anil A.
    El-Rayes, Bassel F.
    Akce, Mehmet
    [J]. CURRENT ONCOLOGY, 2023, 30 (11) : 9789 - 9812
  • [5] SHARP-Study - Sorafenib: soon standard therapy with hepatocellular carcinoma?
    不详
    [J]. ONKOLOGE, 2007, 13 (10): : 962 - 962
  • [6] Cancer Immunotherapy - Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Bai, Jing
    Liang, Ping
    Li, Qian
    Feng, Rui
    Liu, Jiang
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2021, 16 (02) : 239 - 248
  • [7] Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC)
    Berretta, M.
    Cobellis, G.
    Franco, R.
    Panarese, I.
    Rinaldi, B.
    Nasti, G.
    Di Francia, R.
    Rinaldi, L.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (22) : 10139 - 10150
  • [8] Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma
    Chiang, Chi Leung
    Chan, Kenneth Sik Kwan
    Chiu, Keith Wan Hang
    Lee, Francis Ann Shing
    Chen, Wenqi
    Wong, Natalie Sean Man
    Ho, Ryan Lok Man
    Lee, Venus Wan Yan
    Man, Kwan
    Kong, Feng Ming
    Chan, Albert Chi Yan
    [J]. JAMA ONCOLOGY, 2024,
  • [9] Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
    Berretta, Massimiliano
    Rinaldi, Luca
    Di Benedetto, Fabrizio
    Lleshi, Arben
    De Re, Valli
    Facchini, Gaetano
    De Paoli, Paolo
    Di Francia, Raffaele
    [J]. FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [10] Predictors of immunotherapy (IO) response in hepatocellular carcinoma (HCC)
    Armstrong, Samantha Ann
    Singh, Bhavana Pendurthi
    Kulasekaran, Monika
    Prins, Petra
    He, Aiwu Ruth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345